| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.5 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.21 | 0.5 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |